Robot-Assisted Magnetic Resonance Imaging-Targeted versus Systematic Prostate Biopsy; Systematic Review and Meta-Analysis

Introduction: Robot-assisted devices have been recently developed for use in prostate biopsy. However, it is possible advantages over standard biopsy remain unclear. We aimed to assess the diagnostic performance and safety of robot-assisted targeted (RA-TB) and systematic prostate biopsies (RA-SB)....

Full description

Saved in:
Bibliographic Details
Main Authors: Petov, Vladislav (Author) , Azilgareeva, Camilla (Author) , Shpikina, Anastasia (Author) , Morozov, Andrey (Author) , Krupinov, German (Author) , Kozlov, Vasiliy (Author) , Singla, Nirmish (Author) , Gómez Rivas, Juan (Author) , Jesús, Moreno-Sierra (Author) , Puliatti, Stefano (Author) , Checcucci, Enrico (Author) , Rodler, Severin (Author) , Belenchon, Ines Rivero (Author) , Kowalewski, Karl-Friedrich (Author) , Veccia, Alessandro (Author) , Mcfarland, Jonathan (Author) , Cacciamani, Giovanni E. (Author) , Taratkin, Mark (Author) , Enikeev, Dmitry (Author)
Format: Article (Journal)
Language:English
Published: 13 February 2023
In: Cancers
Year: 2023, Volume: 15, Issue: 4, Pages: 1-17
ISSN:2072-6694
DOI:10.3390/cancers15041181
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers15041181
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/15/4/1181
Get full text
Author Notes:Vladislav Petov, Camilla Azilgareeva, Anastasia Shpikina, Andrey Morozov, German Krupinov, Vasiliy Kozlov, Nirmish Singla, Juan Gómez Rivas, Moreno-Sierra Jesús, Stefano Puliatti, Enrico Checcucci, Severin Rodler, Ines Rivero Belenchon, Karl-Friedrich Kowalewski, Alessandro Veccia, Jonathan Mcfarland, Giovanni E. Cacciamani, Mark Taratkin, and Dmitry Enikeev
Description
Summary:Introduction: Robot-assisted devices have been recently developed for use in prostate biopsy. However, it is possible advantages over standard biopsy remain unclear. We aimed to assess the diagnostic performance and safety of robot-assisted targeted (RA-TB) and systematic prostate biopsies (RA-SB). Methods: A systematic literature search was performed in MEDLINE and Scopus databases. The detailed search strategy is available at Prospero (CRD42021269290). The primary outcome was the clinically significant prostate cancer (PCa) detection rate. The secondary outcomes included the overall detection rate of PCa, cancer detection rate per core, and complications. Results: The clinically significant cancer detection rate, overall cancer detection rate, and “per patient” did not significantly differ between RA-TB and RA-SB [OR = 1.02 (95% CI 0.83; 1.26), p = 0.05, I2 = 62% and OR = 0.95 (95% CI 0.78; 1.17), p = 0.17, I2 = 40%, respectively]. There were no differences in the clinically insignificant cancer detection rate “per patient” between RA-TB and RA-SB [OR = 0.81 (95% CI 0.54; 1.21), p = 0.31, I2 = 0%]. RA-TB had a significantly higher cancer detection rate “per core” [OR = 3.01 (95% CI 2.77; 3.27), p < 0.0001, I2 = 96%]. Conclusion: RA-TB and RA-SB are both technically feasible and have comparable clinical significance and overall PCa detection rates.
Item Description:Gesehen am 01.10.2024
Physical Description:Online Resource
ISSN:2072-6694
DOI:10.3390/cancers15041181